FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1539442301> ?p ?o ?g. }

• W1539442301 endingPage "6143" @default.
• W1539442301 startingPage "6136" @default.
• W1539442301 abstract "BACKGROUND: Although studies of melphalan-based isolated limb infusion (ILI) combine data from upper extremity (UE) treatments with those from lower extremity (LE) treatments, differences between the 2 may be clinically important. METHODS: Candidates for UE ILI (n = 51) and LE ILI (n = 192) were identified from prospective databases at 2 institutions. The Response Evaluation Criteria in Solid Tumors and Wieberdink toxicity scale were used as appropriate. RESULTS: The following patients had indications for UE ILI: melanoma, 36 of 47 patients (77%); sarcoma, 5 of 47 patients (11%); Merkel cell sarcoma, 3 of 47 patients (6%), and squamous cell carcinoma, 3 of 47 patients (6%). The patients who underwent UE ILI, as expected, had lower limb volumes (mean, 2.5 L vs 8.6 L; P < .001) and lower mean melphalan doses (20.7 mg vs 49.5 mg; P < .001). On perfusate blood gas analysis, the mean base excess at 30 minutes (−13.9 vs −9.1; P < .001) and the mean pH at 30 minutes (7.06 vs 7.15; P < .001) were lower for UE procedures than for LE procedures, although the mean ischemic time was longer in LE procedures (67.2 minutes) than in UE procedures (61.6 minutes; P = .03). The rate of regional toxicity grade ≥3 for UE ILI was 7% compared with 24% (P = .005) for LE ILI. There was no difference in the complete response rate for melanoma UE procedures (28%; 95% confidence interval, 16%-44%) compared with LE ILI procedures (32%; 95% confidence interval, 25%-39%). CONCLUSIONS: ILI for UE disease was associated with similar complete response rates but lower toxicity than ILI for LE disease and with different physiologic sequelae despite comparable methods. The UE appears relatively resistant to toxic effects of melphalan-based ILI as currently performed, which suggests a potential for further optimization of drug dosing for UE ILI. Cancer 2012. © 2012 American Cancer Society." @default.
• W1539442301 created "2016-06-24" @default.
• W1539442301 creator A5015827608 @default.
• W1539442301 creator A5017340221 @default.
• W1539442301 creator A5020180712 @default.
• W1539442301 creator A5021981756 @default.
• W1539442301 creator A5026301572 @default.
• W1539442301 creator A5033995118 @default.
• W1539442301 creator A5050528758 @default.
• W1539442301 creator A5062453932 @default.
• W1539442301 creator A5071519548 @default.
• W1539442301 creator A5077881806 @default.
• W1539442301 creator A5087882223 @default.
• W1539442301 date "2012-06-06" @default.
• W1539442301 modified "2023-10-06" @default.
• W1539442301 title "A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion" @default.
• W1539442301 cites W162793884 @default.
• W1539442301 cites W1965951004 @default.
• W1539442301 cites W1979390026 @default.
• W1539442301 cites W1998402899 @default.
• W1539442301 cites W2028699294 @default.
• W1539442301 cites W2033253362 @default.
• W1539442301 cites W2040162206 @default.
• W1539442301 cites W2049903029 @default.
• W1539442301 cites W2079406854 @default.
• W1539442301 cites W2087676114 @default.
• W1539442301 cites W2088851921 @default.
• W1539442301 cites W2168228799 @default.
• W1539442301 doi "https://doi.org/10.1002/cncr.27676" @default.
• W1539442301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5161098" @default.
• W1539442301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22674423" @default.
• W1539442301 hasPublicationYear "2012" @default.
• W1539442301 type Work @default.
• W1539442301 sameAs 1539442301 @default.
• W1539442301 citedByCount "14" @default.
• W1539442301 countsByYear W15394423012013 @default.
• W1539442301 countsByYear W15394423012014 @default.
• W1539442301 countsByYear W15394423012015 @default.
• W1539442301 countsByYear W15394423012018 @default.
• W1539442301 countsByYear W15394423012019 @default.
• W1539442301 countsByYear W15394423012020 @default.
• W1539442301 countsByYear W15394423012023 @default.
• W1539442301 crossrefType "journal-article" @default.
• W1539442301 hasAuthorship W1539442301A5015827608 @default.
• W1539442301 hasAuthorship W1539442301A5017340221 @default.
• W1539442301 hasAuthorship W1539442301A5020180712 @default.
• W1539442301 hasAuthorship W1539442301A5021981756 @default.
• W1539442301 hasAuthorship W1539442301A5026301572 @default.
• W1539442301 hasAuthorship W1539442301A5033995118 @default.
• W1539442301 hasAuthorship W1539442301A5050528758 @default.
• W1539442301 hasAuthorship W1539442301A5062453932 @default.
• W1539442301 hasAuthorship W1539442301A5071519548 @default.
• W1539442301 hasAuthorship W1539442301A5077881806 @default.
• W1539442301 hasAuthorship W1539442301A5087882223 @default.
• W1539442301 hasBestOaLocation W15394423011 @default.
• W1539442301 hasConcept C126322002 @default.
• W1539442301 hasConcept C141071460 @default.
• W1539442301 hasConcept C142724271 @default.
• W1539442301 hasConcept C2776694085 @default.
• W1539442301 hasConcept C2778256501 @default.
• W1539442301 hasConcept C2778684742 @default.
• W1539442301 hasConcept C2778822529 @default.
• W1539442301 hasConcept C2779984678 @default.
• W1539442301 hasConcept C29730261 @default.
• W1539442301 hasConcept C42219234 @default.
• W1539442301 hasConcept C44249647 @default.
• W1539442301 hasConcept C71924100 @default.
• W1539442301 hasConceptScore W1539442301C126322002 @default.
• W1539442301 hasConceptScore W1539442301C141071460 @default.
• W1539442301 hasConceptScore W1539442301C142724271 @default.
• W1539442301 hasConceptScore W1539442301C2776694085 @default.
• W1539442301 hasConceptScore W1539442301C2778256501 @default.
• W1539442301 hasConceptScore W1539442301C2778684742 @default.
• W1539442301 hasConceptScore W1539442301C2778822529 @default.
• W1539442301 hasConceptScore W1539442301C2779984678 @default.
• W1539442301 hasConceptScore W1539442301C29730261 @default.
• W1539442301 hasConceptScore W1539442301C42219234 @default.
• W1539442301 hasConceptScore W1539442301C44249647 @default.
• W1539442301 hasConceptScore W1539442301C71924100 @default.
• W1539442301 hasIssue "24" @default.
• W1539442301 hasLocation W15394423011 @default.
• W1539442301 hasLocation W15394423012 @default.
• W1539442301 hasLocation W15394423013 @default.
• W1539442301 hasLocation W15394423014 @default.
• W1539442301 hasOpenAccess W1539442301 @default.
• W1539442301 hasPrimaryLocation W15394423011 @default.
• W1539442301 hasRelatedWork W2053544339 @default.
• W1539442301 hasRelatedWork W2055774937 @default.
• W1539442301 hasRelatedWork W2056199365 @default.
• W1539442301 hasRelatedWork W2093413695 @default.
• W1539442301 hasRelatedWork W2139391544 @default.
• W1539442301 hasRelatedWork W2278636047 @default.
• W1539442301 hasRelatedWork W2316630565 @default.
• W1539442301 hasRelatedWork W2772670513 @default.
• W1539442301 hasRelatedWork W3031735911 @default.
• W1539442301 hasRelatedWork W422559985 @default.
• W1539442301 hasVolume "118" @default.
• W1539442301 isParatext "false" @default.

• next